VESIcare - 51248-150-52 - (solifenacin succinate)

Alphabetical Index


Drug Information of VESIcare

Product NDC: 51248-150
Proprietary Name: VESIcare
Non Proprietary Name: solifenacin succinate
Active Ingredient(s): 5    mg/1 & nbsp;   solifenacin succinate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of VESIcare

Product NDC: 51248-150
Labeler Name: Astellas Pharma Technologies, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021518
Marketing Category: NDA
Start Marketing Date: 20050105

Package Information of VESIcare

Package NDC: 51248-150-52
Package Description: 100 TABLET, FILM COATED in 1 BLISTER PACK (51248-150-52)

NDC Information of VESIcare

NDC Code 51248-150-52
Proprietary Name VESIcare
Package Description 100 TABLET, FILM COATED in 1 BLISTER PACK (51248-150-52)
Product NDC 51248-150
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name solifenacin succinate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20050105
Marketing Category Name NDA
Labeler Name Astellas Pharma Technologies, Inc.
Substance Name SOLIFENACIN SUCCINATE
Strength Number 5
Strength Unit mg/1
Pharmaceutical Classes Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]

Complete Information of VESIcare


General Information